Ocular Genomics Institute of Massachusetts Eye and Ear, Harvard Medical School.
Ocular Genomics Institute of Massachusetts Eye and Ear, Harvard Medical School;
J Vis Exp. 2021 Feb 10(168). doi: 10.3791/62228.
Eye disorders affect millions of people worldwide, but the limited availability of human tissues hinders their study. Mouse models are powerful tools to understand the pathophysiology of ocular diseases because of their similarities with human anatomy and physiology. Alterations in the retinal pigment epithelium (RPE), including changes in morphology and function, are common features shared by many ocular disorders. However, successful isolation and culture of primary mouse RPE cells is very challenging. This paper is an updated audiovisual version of the protocol previously published by Fernandez-Godino et al. in 2016 to efficiently isolate and culture primary mouse RPE cells. This method is highly reproducible and results in robust cultures of highly polarized and pigmented RPE monolayers that can be maintained for several weeks on Transwells. This model opens new avenues for the study of the molecular and cellular mechanisms underlying eye diseases. Moreover, it provides a platform to test therapeutic approaches that can be used to treat important eye diseases with unmet medical needs, including inherited retinal disorders and macular degenerations.
眼部疾病影响着全球数百万人,但由于人类组织的有限供应,限制了对其的研究。由于与人类解剖和生理学的相似性,鼠类模型是研究眼部疾病病理生理学的有力工具。视网膜色素上皮(RPE)的改变,包括形态和功能的改变,是许多眼部疾病的共同特征。然而,成功分离和培养原代鼠 RPE 细胞是极具挑战性的。本文是 Fernandez-Godino 等人于 2016 年发表的该方案的更新视听版本,该方案可有效地分离和培养原代鼠 RPE 细胞。该方法具有高度的可重复性,可获得高度极化和色素沉着的 RPE 单层的健壮培养物,这些培养物可在 Transwell 上维持数周。该模型为研究眼部疾病的分子和细胞机制开辟了新途径。此外,它为测试治疗方法提供了一个平台,这些方法可用于治疗具有未满足医疗需求的重要眼部疾病,包括遗传性视网膜疾病和黄斑变性。